Faster insulin aspart shows real-world efficacy for T1D
25 Sep 2020
bởiTristan Manalac
For patients with type 1 diabetes (T1D), switching to faster insulin aspart may improve glycated haemoglobin (HbA1c), time-in-range (TIR), and time in hyperglycaemia, without posing serious hypoglycaemia risks, according to a new study.